And Many Thanks to Our Corporate Supporters!

"RSN continues to serve the kidney community by instilling health, happiness, and hope through education, advocacy, and awareness... one person at a time."  Thank you for your support of our mission.

Amgen Logo

Amgen discovers, develops, manufactures, and delivers innovative human therapeutics. A leader in biotechnology since 1980, Amgen was one of the first companies to realize the new science’s promise by bringing safe, effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, bone disease, and other serious illnesses. Amgen pioneered the development of novel products based on advances in recombinant DNA and molecular biology, and launched the biotechnology industry’s first blockbuster medicines. Amgen continues to be an entrepreneurial, science-driven enterprise dedicated to helping people fight serious illness. To learn more about our pioneering science and our vital medicines, visit

Astellas Pharma, Inc

Astellas and its affiliated US entities, subsidiaries of Tokyo-based Astellas Pharma, Inc., are a research-based pharmaceutical company dedicated to improving the health of people around the world through innovative pharmaceutical products. Astellas has been dedicated to the field of immunology for nearly twenty years and is the leader in transplantation. Astellas ranks among the top 20 pharmaceutical companies in the world and will continue to grow as a competitive company in the world pharmaceutical market. For more information on Astellas, please go to or

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Oncology, Cardiovascular & Metabolic Diseases and Respiratory. The Company also is selectively active in the areas of autoimmunity, neuroscience and infection. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information, please visit and follow us on Twitter @AstraZenecaUS.



Baxter International Inc. develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide.


DaVita Kidney Care is a division of DaVita HealthCare Partners Inc., a Fortune 500® company that, through its operating divisions, provides a variety of health care services to patient populations throughout the United States and abroad. A leading provider of dialysis services in the United States, DaVita Kidney Care treats patients with chronic kidney failure and end stage renal disease. DaVita Kidney Care strives to improve patients' quality of life by innovating clinical care, and by offering integrated treatment plans, personalized care teams and convenient health-management services. To learn more please visit us at


The primary responsibility of DCI is to perceive, initiate and provide comprehensive patient care. We serve society by providing care for patients with End-Stage Renal Disease. Our goal is complete patient rehabilitation. We recognize the patient as an individual resulting from his or her genetics, life experience, habits, beliefs, emotions; and as a member of his or her family and the community. The patient deserves the highest standard of care possible regardless of race, status or creed. The application of comprehensive care is on a personal level. We become acquainted with our patient as a person and seek to understand his/her problems and needs- physical, emotional, spiritual and social.

Fresenius Medical Care North America

Fresenius Medical Care North America (FMCNA) is the nation’s leading integrated provider of products and services for individuals with chronic kidney failure, a condition that affects nearly 400,000 Americans, and more than 1,400,000 individuals worldwide. With more than 35,000 employees, FMCNA operates a nationwide network of clinics that provide dialysis treatment. The company also manufactures and distributes dialysis products, performs specialized diagnostic and laboratory testing for renal patients, and provides comprehensive renal disease management services. With corporate offices in Massachusetts, the company is the largest affiliate of German-based Fresenius Medical Care AG, which is in turn the world’s largest provider of products and services for individuals with chronic renal failure. Visit or for more information.

Genentech, considered the founder of the biotechnology industry, has been delivering on the promise of biotechnology for more than 35 years, using human genetic information to discover, develop, manufacture and commercialize medicines to treat patients with serious or life-threatening medical conditions. Today, Genentech is among the world's leading biotech companies, with multiple products on the market and a promising development pipeline. Visit for more information.

Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) is a biopharmaceutical company focused on the research, development and commercialization of pharmaceutical products geared towards addressing unmet needs and providing unique and meaningful advantages to patients with renal disease and their healthcare providers. Patients have been and continue to be at the center of our 16-year corporate history. Keryx is headquartered in New York City, and recently expanded its footprint to Boston, the country’s life sciences hub, to support the US launch of Auryxia™ (ferric citrate). Several functions are housed in the company’s Boston office, including commercial, regulatory, medical affairs, as well as many general and administrative functions. Visit for more information.

Mallinckrodt Pharmaceuticals is a multibillion dollar specialty biopharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to address unmet patient needs, stemming from nearly 150 years of using our unique strengths, experience and expertise to help improve people’s lives. Discover how our rich history of innovation and patient-centered solutions has helped influence our vision for the future. Visit us at

National Renal Administrators Association (NRAA)

NRAA is a nonprofit organization representing independent, regional and community based dialysis providers throughout the United States. NRAA members include renal administrators, nurse managers, nurses, medical directors, technicians and financial/billing managers for dialysis clinics, which provide life-sustaining dialysis care to the majority of Medicare End Stage Renal Disease (ESRD) patients. From a few charter members in 1977, NRAA has become the respected leader in the dialysis community representing the operational concerns of dialysis facilities.  Through education, networking, collaboration and legislative advocacy, NRAA strives to support clinical and financial best practices while enhancing professionalism throughout the kidney community. Call 215-320-4655 or visit for more information.


NxStage, Inc.

NxStage® Medical Inc., is a medical device company headquartered in Lawrence, MA, that develops, manufactures, and markets innovative systems for the treatment of end-stage renal disease and acute kidney failure. Over 5,000 home patients enjoy the freedom and flexibility of the System One™ hemodialysis machine, the first truly portable system indicated for home hemodialysis. In hospital ICUs, NxStage is the equipment of choice for 8 of the top 10 kidney disease hospitals (as ranked by US News & World Report). Medisystems, a NxStage company, is the market leader in tubing and access needle products in US dialysis centers.  Visit for more information.


Rockwell Medical is a fully-integrated biopharmaceutical company targeting end-stage renal and chronic kidney disease with innovative products and services for the treatment of iron deficiency anemia, secondary hyperparathyroidism and hemodialysis. Triferic, is the only FDA approved iron drug indicated to replace iron and maintain hemoglobin in hemodialysis patients suffering from anemia.   Via dialysate during each dialysis treatment, Triferic replaces the 5-7 mg iron loss that occurs in all patients, effectively maintaining their iron balance, addressing a significant unmet need in overcoming Functional Iron Deficiency (FID) in ESRD patients. For more information, visit

U.S. Renal Care was founded in 2000 and serves more than 23,000 patients in 300 dialysis facilities in 33 states and the Territory of Guam. We have a unique business model, developing and operating dialysis centers in joint venture partnerships with leading local nephrologists.

Roche, Inc.

ZS Pharma is a biopharmaceutical company committed to the development and commercialization of highly selective, non-absorbed drugs to treat renal, cardiovascular, liver and metabolic diseases. Our initial focus is on the development of ZS-9, our product candidate in Phase 3 development for the treatment of hyperkalemia, a life-threatening condition characterized by abnormally high levels of potassium in the blood. Visit for more information.